Invention Grant
US09023838B2 Crystalline form I rosuvastatin zinc salt 有权
结晶形式I瑞舒伐他汀锌盐

Crystalline form I rosuvastatin zinc salt
Abstract:
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0